Improving outcomes in peripartum cardiomyopathy

References

• Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12:767-78
   PubMed Web of Science ®Google Scholar
• Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-8
   PubMed Web of Science ®Google Scholar
• Kolte D, Khera S, Aronow WS, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 2014;3:e001056
   PubMed Web of Science ®Google Scholar
• Mielniczuk LM, Williams K, Davis DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol 2006;97:1765-8
   PubMed Web of Science ®Google Scholar
• Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007;100:302-4
   PubMed Web of Science ®Google Scholar
• Gentry MB, Dias JK, Luis A, et al. African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol 2010;55:654-9
   PubMed Web of Science ®Google Scholar
• Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005;80:1602-6
   PubMed Web of Science ®Google Scholar
• Chee KH, Azman W. Prevalence and outcome of peripartum cardiomyopathy in Malaysia. Int J Clin Pract 2009;63:722-5
   PubMed Web of Science ®Google Scholar
• Cenac A, Djibo A. Postpartum cardiac failure in Sudanese-Sahelian Africa: clinical prevalence in western Niger. Am J Trop Med Hyg 1998;58:319-23
   PubMed Web of Science ®Google Scholar
• Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 2007;17:228-33
   PubMed Web of Science ®Google Scholar
• Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84
   PubMed Web of Science ®Google Scholar
• Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050-5
   PubMed Web of Science ®Google Scholar
• Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 2000;140:785-91
   PubMed Web of Science ®Google Scholar
• Forster O, Hilfiker-Kleiner D, Ansari AA, et al. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 2008;10:861-8
   PubMed Web of Science ®Google Scholar
• Sliwa K, Skudicky D, Bergemann A, et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000;35:701-5
   PubMed Web of Science ®Google Scholar
• Sliwa K, Förster O, Libhaber E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006;27:441-6
   PubMed Web of Science ®Google Scholar
• Goland S, Modi K, Bitar F, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 2009;15:645-50
   PubMed Web of Science ®Google Scholar
• Duran N, Günes H, Duran I, et al. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 2008;101:137-40
   PubMed Web of Science ®Google Scholar
• Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006;152:509-13
   PubMed Web of Science ®Google Scholar
• Chapa JB, Heiberger HB, Weinert L, et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005;105:1303-8
   PubMed Web of Science ®Google Scholar
• Pillarisetti J, Kondur A, Alani A, et al. Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use. J Am Coll Cardiol 2014;63:2831-9
   PubMed Web of Science ®Google Scholar
• Kao DP, Hsich E, Lindenfeld J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail 2013;1:409-16
   PubMed Web of Science ®Google Scholar
• Haghikia A, Podewski E, Libhaber E, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 2013;108:366
   PubMed Web of Science ®Google Scholar
• Chee KH. Favourable outcome after peripartum cardiomyopathy: a ten-year study on peripartum cardiomyopathy in a university hospital. Singapore Med J 2013;54:28-31
   PubMed Web of Science ®Google Scholar
• Blauwet LA, Libhaber E, Forster O, et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart 2013;99:308-13
   PubMed Web of Science ®Google Scholar
• Horgan SJ, Margey R, Brennan DJ, et al. Natural history, management, and outcomes of peripartum cardiomyopathy: an Irish single-center cohort study. J Matern Fetal Neonatal Med 2013;26:161-5
   PubMed Web of Science ®Google Scholar
• Biteker M, Ilhan E, Biteker G, et al. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J Heart Fail 2012;14:895-901
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847
   PubMed Web of Science ®Google Scholar
• Saltzberg MT, Szymkiewicz S, Bianco NR. Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 2012;18:21-7
   PubMed Web of Science ®Google Scholar
• Duncker D, Haghikia A, König T, et al. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Eur J Heart Fail 2014;16:1331-6
   PubMed Web of Science ®Google Scholar
• Toescu V, Nuttall SL, Martin U, et al. Oxidative stress and normal pregnancy. Clin Endocrinol (Oxf) 2002;57:609-13
   PubMed Web of Science ®Google Scholar
• Ricke-Hoch M, Bultmann I, Stapel B, et al. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res 2014;101:587-96
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128:589-600
   PubMed Web of Science ®Google Scholar
• Halkein J, Tabruyn SP, Ricke-Hoch M, et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013;123:2143-54
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Meyer GP, Schieffer E, et al. Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 2007;50:2354-5
   PubMed Web of Science ®Google Scholar
• Habedank D, Kühnle Y, Elgeti T, et al. Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur J Heart Fail 2008;10:1149-51
   PubMed Web of Science ®Google Scholar
• Meyer GP, Labidi S, Podewski E, et al. Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J Med Case Rep 2010;4:80
   PubMedGoogle Scholar
• Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010;121:1465-73
   PubMed Web of Science ®Google Scholar
• Effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy. NCT00998556 (2012). US National Library of Medicine ClinicalTrials.gov 2015. Available from: https://clinicaltrials.gov/ct2/show/NCT00998556
   Google Scholar
• Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012;485:333-8
   PubMed Web of Science ®Google Scholar
• Rickenbacher PR, Rizeq MN, Hunt SA, et al. Long-term outcome after heart transplantation for peripartum cardiomyopathy. Am Heart J 1994;127:1318-23
   PubMed Web of Science ®Google Scholar
• Keogh A, Macdonald P, Spratt P, et al. Outcome in peripartum cardiomyopathy after heart transplantation. J Heart Lung Transplant 1994;13:202-7
   PubMed Web of Science ®Google Scholar
• Rasmusson K, Brunisholz K, Budge D, et al. Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant 2012;31:180-6
   PubMed Web of Science ®Google Scholar
• Loyaga-Rendon RY, Pamboukian SV, Tallaj JA, et al. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail 2014;7:300-9
   PubMed Web of Science ®Google Scholar
• Birks EJ, George RS, Hedger M, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011;123:381-90
   PubMed Web of Science ®Google Scholar
• Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol 2014;64:1629-36
   PubMed Web of Science ®Google Scholar
• Ravikishore AG, Kaul UA, Sethi KK, Khalilullah M. Peripartum cardiomyopathy: prognostic variables at initial evaluation. Int J Cardiol 1991;32:377-80
   PubMed Web of Science ®Google Scholar
• Hu CL, Li YB, Zou YG, et al. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 2007;93:488-90
   PubMed Web of Science ®Google Scholar
• Sliwa K, Hilfiker-Kleiner D, Mebazaa A, et al. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail 2014;16:583-91
   PubMed Web of Science ®Google Scholar